Twenty-three years ago, the Dana-Farber Cancer Institute, a prestigious Harvard teaching hospital, killed a 39-year-old woman undergoing experimental breast cancer treatment by giving her massive overdoses of a chemotherapy drug.
She died as she was preparing to leave the hospital and go home to her two daughters, aged 7 and 3. The doctors didn’t listen to her warnings that there was something terribly wrong, and they missed tests indicating heart damage.
The medication error (four . . .
Want to read more? Please subscribe to The Crime Report!